To read more on this topic click here.
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
Author: Saskia MairPublished: 14 May 2020
Prep: Cook: Serves:
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.
This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.
Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.
Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.
She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”
For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.
Can higher levels of caffeine and uric acid prevent Parkinson’s?
White blood cells could help diagnose people at risk of Parkinson’s, study finds
Share this story
My life at university with Parkinson’s disease
This recent graduate has overcome more than your average studentREAD MORE
In my country
Supporting 100,000 Australians with Parkinson’s
We spoke to the CEO of Parkinson’s AustraliaREAD MORE
DBS: “We are moving past the idea that one treatment fits all”
How Medtronic is tailoring DBS treatment to individual patientsREAD MORE